bluebird bio (BLUE) News Today → The Department of Defense Has a New Drone Contractor (From The Tomorrow Investor) (Ad) Free BLUE Stock Alerts $0.96 -0.05 (-5.38%) (As of 01:46 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineMay 28, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against BLUEprnewswire.com - May 8 at 5:45 AMROSEN, A LEADING NATIONAL FIRM, Encourages bluebird bio Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BLUEprnewswire.com - May 7 at 5:42 PMSHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in bluebird bio, Inc. with Losses of $100,000 to Contact the Firmprnewswire.com - May 7 at 4:05 PMbluebird bio (BLUE) Scheduled to Post Earnings on Thursdaymarketbeat.com - May 7 at 1:26 PMThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 28, 2024 in bluebird bio, Inc. Lawsuit - BLUEprnewswire.com - May 7 at 5:45 AMFirst sickle cell patient begins bluebird gene therapy treatmentbizjournals.com - May 6 at 4:16 PMbluebird bio Announces First Quarter 2024 Results Call Date and Upcoming Investor Eventsbusinesswire.com - May 6 at 7:05 AMbluebird bio Announces Completion of First Cell Collection for LYFGENIA™ Gene Therapybusinesswire.com - May 6 at 7:00 AMLevi & Korsinsky Notifies Shareholders of bluebird bio, Inc.(BLUE) of a Class Action Lawsuit and an Upcoming Deadlineprnewswire.com - May 6 at 5:45 AMSHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Blueprnewswire.com - May 3 at 9:45 AMClass Action Filed Against bluebird bio, Inc. (BLUE) - May 28, 2024 Deadline to Join - Contact The Gross Law Firmprnewswire.com - May 3 at 5:45 AMSweetwater's big fourth inning carries them past Polk Countymsn.com - May 3 at 1:36 AMBLUE Investors Have Opportunity to Lead bluebird bio, Inc. Securities Fraud Lawsuitprnewswire.com - May 2 at 12:00 PMbluebird bio, Inc. (NASDAQ:BLUE) Short Interest Updateamericanbankingnews.com - May 2 at 5:30 AMROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages bluebird bio Inc. Investors to Inquire About Securities Class Action Investigation - BLUEmarkets.businessinsider.com - May 1 at 11:57 PMSHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in bluebird bio, Inc. with Losses of $100,000 to Contact the Firmprnewswire.com - May 1 at 11:15 AMShort Interest in bluebird bio, Inc. (NASDAQ:BLUE) Grows By 9.6%marketbeat.com - April 30 at 9:35 AMBLUE Investors Have Opportunity to Lead bluebird bio, Inc. Securities Fraud Lawsuitprnewswire.com - April 29 at 5:45 PMBLUE INVESTOR NOTICE: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages bluebird bio Inc. Investors to Inquire About Securities Class Action Investigation - BLUEprnewswire.com - April 29 at 3:03 PMSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against bluebird bio, Inc. - BLUEprnewswire.com - April 28 at 9:00 AMBLUE INVESTOR NEWS: TOP RANKED ROSEN LAW FIRM Encourages bluebird bio Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BLUEprnewswire.com - April 27 at 1:45 PMONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of bluebird biomarkets.businessinsider.com - April 27 at 10:25 AMBLUE LOSS ALERT: TOP RANKED ROSEN LAW FIRM Encourages bluebird bio Inc. Investors to Inquire About Securities Class Action Investigation - BLUEstockhouse.com - April 27 at 12:24 AMbluebird bio Announces Receipt of Expected Notice from Nasdaqbusinesswire.com - April 26 at 4:05 PMBLUE LAWSUIT ALERT: The Gross Law Firm Notifies bluebird bio, Inc. Investors of a Class Action Lawsuit and Upcoming Deadlineprnewswire.com - April 26 at 5:45 AMBLUE LAWSUIT ALERT: The Gross Law Firm Notifies bluebird bio, Inc. Investors of a Class Action Lawsuit and Upcoming Deadlineprnewswire.com - April 26 at 5:45 AMSHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Blueprnewswire.com - April 25 at 1:00 PMBLUE Equity Alert: ROSEN, A Top Ranked Law Firm, Encourages bluebird bio Inc. Investors to Inquire About Securities Class Action Investigation - BLUEstockhouse.com - April 24 at 11:53 PMBLUE Investors Have Opportunity to Lead bluebird bio, Inc. Securities Fraud Lawsuitprnewswire.com - April 24 at 3:15 PMBluebird bio Incmoney.usnews.com - April 23 at 5:54 AMSHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in bluebird bio, Inc. with Losses of $100,000 to Contact the Firmprnewswire.com - April 23 at 12:30 AMLost Money on bluebird bio, Inc.(BLUE)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinskyprnewswire.com - April 22 at 6:10 AMROSEN, National Trial Lawyers, Encourages bluebird bio Inc. Investors to Inquire About Securities Class Action Investigation - BLUEmarkets.businessinsider.com - April 21 at 8:27 PMSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against bluebird bio, Inc. - BLUEprnewswire.com - April 20 at 9:00 AMINVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in bluebird bio, Inc. with Losses of $100,000 to Contact the Firmstockhouse.com - April 19 at 3:15 PMbluebird bio, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - BLUEprnewswire.com - April 19 at 5:45 AMBLUE Investors Have Opportunity to Lead bluebird bio, Inc. Securities Fraud Lawsuitprnewswire.com - April 18 at 3:50 PMbluebird bio (BLUE) Price Target Decreased by 7.15% to 4.24msn.com - April 17 at 4:06 PMROSEN, NATIONAL TRIAL LAWYERS, Encourages bluebird bio Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BLUEprnewswire.com - April 17 at 3:52 PMClass Action Filed Against bluebird bio, Inc. (BLUE) Seeking Recovery for Investors - Contact The Gross Law Firmprnewswire.com - April 16 at 5:45 AMTD Cowen says sickle cell therapies may get higher CMS paymentsmsn.com - April 16 at 3:21 AMBLUE Investors Have Opportunity to Lead bluebird bio, Inc. Securities Fraud Lawsuitprnewswire.com - April 15 at 11:00 AMIs Bluebird Bio Stock a Buy?fool.com - April 15 at 8:15 AMbluebird bio, Inc. Class Action: Levi & Korsinsky Reminds bluebird bio Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 28, 2024 - BLUEprnewswire.com - April 15 at 5:45 AMROSEN, LEADING TRIAL ATTORNEYS, Encourages bluebird bio Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BLUEstockhouse.com - April 14 at 9:18 PMbluebird bio, Inc. (NASDAQ:BLUE) Short Interest Down 12.6% in Marchmarketbeat.com - April 14 at 5:32 PMDEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Bluemarkets.businessinsider.com - April 14 at 10:17 AMROSEN, A Leading Law Firm, Encourages bluebird bio Inc. Investors to Inquire About Securities Class Action Investigation - BLUEmarkets.businessinsider.com - April 13 at 11:45 PMBetter Buy: Bluebird Bio Vs. Novavaxfool.com - April 13 at 4:22 PMROSEN, GLOBAL INVESTOR COUNSEL, Encourages bluebird bio Inc. Investors to Inquire About Securities Class Action Investigation - BLUEprnewswire.com - April 12 at 7:23 PM Get bluebird bio News Delivered to You Automatically Sign up to receive the latest news and ratings for BLUE and its competitors with MarketBeat's FREE daily newsletter. Email Address Incredible Opportunity to Retire FAST! (Ad)A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market. Click here to get instant access to the guide BLUE Media Mentions By Week BLUE Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BLUE News Sentiment▼0.090.38▲Average Medical News Sentiment BLUE News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BLUE Articles This Week▼166▲BLUE Articles Average Week Get bluebird bio News Delivered to You Automatically Sign up to receive the latest news and ratings for BLUE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Vigil Neuroscience News Today AlloVir News Today Curis News Today aTyr Pharma News Today Sangamo Therapeutics News Today BioAtla News Today Protalix BioTherapeutics News Today Atara Biotherapeutics News Today Passage Bio News Today CEL-SCI News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BLUE) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorElon Musk Secret Crypto Plot ExposedCrypto 101 MediaAI “wealth window” is closing June 25thParadigm PressCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward PressThe #1 lithium battery stock to have on your radar in 2024!Smallcaps DailyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing[URGENT] DO NOT Touch These AI Stocks!Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding bluebird bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
